Module Database Search



MODULE DESCRIPTOR
Module Title
Medicinal Analysis And Aseptic Control
Reference PH3131 Version 5
Created August 2021 SCQF Level SCQF 9
Approved March 2013 SCQF Points 30
Amended August 2021 ECTS Points 15

Aims of Module
To develop knowledge and understanding of the principles and concepts of methods to assure quality of medicines for patients through aseptic manipulation, quality assurance, and the qualitative and quantitative analysis of medicinal products.

Learning Outcomes for Module
On completion of this module, students are expected to be able to:
1 Appraise the major qualitative and quantitative analytical techniques used for the quality assurance of medicinal products.
2 Generate, apply, document and interpret data from instrumental techniques in both quantitative and qualitative analysis of medicinal products.
3 Apply the principles of clean room design, operation and working practices.
4 Apply the principles of the preparation, supply and testing of aseptically prepared sterile products including the design, manufacture and production of radiopharmaceuticals.

Indicative Module Content
The application of instrumental and aseptic techniques in the preparation and quality assurance of medicinal products. Topics include: purpose of pharmacopoeial, pharmaceutical and biopharmaceutical analyses; characterisation, evaluation and selection of assay methods; drug assays and structure elucidation by UV, IR, Raman, fluorescence, atomic spectroscopy, NMR and MS; drug quality and quantity by UV, fluorescence, TLC, GLC and HPLC; the design and operation of clean work areas; methods of manufacture and testing sterile products, aseptic preparation and supply processes, including cold chain; the production of radiopharmaceuticals; Quality Assurance systems for manufacturing, preparing and supply of medicines; the role of Good Manufacturing Practice (GMP) and Quality Control (QC) in the manufacture of sterile products.

Module Delivery
Lectures, coursework sessions (including laboratory work, tutorials, workshops) and input from industrial and hospital pharmacists, directed study.

Indicative Student Workload Full Time Part Time
Contact Hours 94 N/A
Non-Contact Hours 206 N/A
Placement/Work-Based Learning Experience [Notional] Hours N/A N/A
TOTAL 300 N/A
Actual Placement hours for professional, statutory or regulatory body    

ASSESSMENT PLAN
If a major/minor model is used and box is ticked, % weightings below are indicative only.
Component 1
Type: Examination Weighting: 80% Outcomes Assessed: 1, 3, 4
Description: 2 hour written examination
Component 2
Type: Coursework Weighting: 20% Outcomes Assessed: 2
Description: Lab report on a practical experiment

MODULE PERFORMANCE DESCRIPTOR
Explanatory Text
The first grade represents Component 1 (EX1) weighted as major and the second, Component 2 (CW1), weighted as minor. A minimum of Grade D or better is required to pass the module. Non-submission of either component will result in an NS grade.
Module Grade Minimum Requirements to achieve Module Grade:
A AA,AB,AC
B BA,BB,BC,BD,AD,CA
C CB,CC,CD,DA,DB
D DC,DD
E EA,EB,EC,ED,EE,EF,AE,BE,CE,DE,AF,BF,CF,DF,FA,FB,FC
F FD,FE,FF
NS Non-submission of work by published deadline or non-attendance for examination

Module Requirements
Prerequisites for Module Successful completion of MPharm stage 2.
Corequisites for module None.
Precluded Modules None.

INDICATIVE BIBLIOGRAPHY
1 WATSON, D., Pharmaceutical Analysis. Current Edition. London: Churchill Livingstone.
2 WILLIAMS, D.H. and FLEMING, I., Spectroscopic Methods in Organic Chemistry. Current Edition. London: McGraw-Hill.
3 HM STATIONERY OFFICE, British Pharmacopoeia. London: HMSO and via web-site.
4 WINFIELD, A.J., REES, J. and SMITH, I. Pharmaceutical Practice. Current Edition. London: Elsevier Science.
5 BEANEY, A.M. Quality Assurance of Aseptic Preparation Services. Current Edition. London: Pharmaceutical Press.


Robert Gordon University, Garthdee House, Aberdeen, AB10 7QB, Scotland, UK: a Scottish charity, registration No. SC013781